RECRUITING

Acupuncture Therapy and Hypertension

Talk to us

Conditions

Mild to Moderate Hypertensionhypertension, electroacupuncture

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.

Official Title

Neuroimmune Mechanisms Underlying Electroacupuncture Effect on Vascular Function

Quick Facts

Study Start:2023-01-01
Study Completion:2027-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05530512

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Subjects from 45 to 75 years of age
  2. 2. Clinically diagnosed with mild to moderate hypertension and ON or OFF medication (Office SBP \> 140 mmHg and \< 160 mmHg Or ABPM average SBP \> 130 mmHg and \< 145 mmHg), and
  3. 3. No significant ECG change reflecting ischemia (i.e. ST elevation or depression) at rest will be recruited to participate in this study.
  1. 1. Subjects will be excluded if on anti-hypertensive medications.
  2. 2. Subjects will be excluded if pregnant or nursing.
  3. 3. Subjects will be excluded if they have coronary disease (by history or on ECG screening), conduction abnormalities on ECG consistent with left bundle branch block, cardiac arrhythmias associated with low blood pressure (\<90 mmHg), peripheral vascular disease, orthopedic disease, diabetic neuropathy or severe hypertension (BP \>170 mmHg systolic or \>110 mmHg diastolic), or any other physical or psychological illness.
  4. 4. Those with known sensitivity to any topical preparations or strong reactions to medical dressings and skin tapes also will be excluded.
  5. 5. Inability our or unwillingness of individual to give written informed consent.

Contacts and Locations

Study Contact

Ashwini Erande
CONTACT
7144567025
aerande@hs.uci.edu

Principal Investigator

Shaista Malik
PRINCIPAL_INVESTIGATOR
University of California, Irvine

Study Locations (Sites)

Susan Samueli Integrative Health Institute
Irvine, California, 92697
United States
University of California, Irvine, Health Sciences Medical Center
Orange, California, 92868
United States

Collaborators and Investigators

Sponsor: University of California, Irvine

  • Shaista Malik, PRINCIPAL_INVESTIGATOR, University of California, Irvine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-01-01
Study Completion Date2027-03-31

Study Record Updates

Study Start Date2023-01-01
Study Completion Date2027-03-31

Terms related to this study

Keywords Provided by Researchers

  • hypertension, electroacupuncture

Additional Relevant MeSH Terms

  • Mild to Moderate Hypertension